HIV Homecare - Medication and Home Delivery
The value below is a framework or dynamic market ceiling: the maximum
that could be spent across all call-offs, not the value of a single contract.
Aggregate figures on this site exclude these to avoid double counting.
key details
| Value | £9,340,426 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Region | South East |
| Deadline | 26 Mar 2026 |
| Contract start | 1 Apr 2026 |
| Contract end | 31 Mar 2028 |
| Procedure | selective |
| SME suitable | No |
| OCID | ocds-b5fd17-8277f305-e95e-47b2-a93f-e378d97fec50 |
Award
| Supplier | Value | Date | Status |
|---|---|---|---|
| Alcura UK Limited | £18,680,852 | 26 Mar 2026 | active |
description
Contract for the provision of the supply and home delivery of Medication for Patients, with the option to extend for 24 months in 2 x tranches of 12 months each. This is a call off agreement under the PCR 2015 regulations, framework reference: Homecare Medicines Services OJEU Ref: 2021/S 000-028751
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 17 Jun 2026 | Award (award) | · | df0930c6-400d-4e7c-a30a-9e9a5dcdb92b-902526 |
more from Kent Community Health N H S Foundation Trust
- Multi-Factor Authentication & Single Sign On (MFA/SSO) IT System · £517,000 · 13 May 2026
- Privileged Access Management IT System · £146,000 · 13 May 2026
- Podiatric surgical fixation (screws etc) · £154,020 · 7 May 2026
- Provision of legal services · £100,000 · 20 Mar 2026
- POCT Equipment (Reactive Proteins) · £160,000 · 28 Jan 2026
- Paediatric Orthotic Services · £1,470,000 · 28 Jan 2026
- Water & Waste Water · £390,000 · 16 Oct 2025
- Security & CCTV (PPM & Reactive) · £350,000 · 22 Sept 2025
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.